Immune Globulins
J5 · Effective Oct 1, 2015
6 active Medicare policies list 96365, and 17 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
J5 · Effective Jul 1, 2026
J6 · Effective Jul 1, 2026
17 policies from 7 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 96365 |
|---|---|---|
| Aldesleukin (Proleukin) | Sep 21, 2023 | Covered |
| Histamine Desensitization Therapy for Intractable Headaches | Sep 13, 2023 | Covered |
| Panitumumab (Vectibix) | Feb 5, 2024 | Covered |
| Policy | Effective | Status of 96365 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders |
| Jan 1, 2026 |
| Covered |
| Onasemnogene abeparvovec-xioi | Jan 1, 2026 | Covered |
|---|
| Policy | Effective | Status of 96365 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Jan 1, 2026 | Covered |
| Onasemnogene abeparvovec-xioi | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 96365 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Jan 1, 2026 | Covered |
| Onasemnogene abeparvovec-xioi | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 96365 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Jan 1, 2026 | Covered |
| Onasemnogene abeparvovec-xioi | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 96365 |
|---|---|---|
| Attention Deficit Hyperactivity Disorder Assessment and Treatment | Not recorded | Covered |
| Policy | Effective | Status of 96365 |
|---|---|---|
| Parenteral Antibiotics for the Treatment of Lyme Disease | Jan 6, 2026 | Covered |